Arensia Strategy Dinner -The New Normal In Exploratory Clinical Trials : Challenges and Future Trends

WHAT TO EXPECT

Our Unique Meeting Format

In today’s fast-changing world, staying competitive requires innovative thinking and adaptability. With the rise of novel technologies, keeping the pulse on developments has become more critical than ever before. The Clinical Development industry is facing competition with unprecedented challenges caused by disruptive events. Application of innovative strategies has proven that early phase clinical trials can maintain necessary flexibility and can be executed on time and within budget.

After 3 years of virtual meetings, we are excited to meet face-to-face for an interactive roundtable discussion. In an informal setting, industry thought leaders will have an opportunity to exchange their vision of paradigm shifts in early clinical development. The focus will be on practical aspects of the new normal in planning and execution of early phase clinical trials.

Among other exciting topics, we will discuss:
-Understanding that Early Phase Trials are not small-scale Phase III trials
-Enhancing Cohort Management through reducing the number of sites
-Strategies for flexibility and resilience embedded into study designs
-Future Concepts for Early Phase Clinical Trials

Our Unique Meeting Format

Dr. Claudia Hesselmann,
PhD, Co-founder & CEO
ARENSIA

Dr. Natalia Pirtac
Manager Trial Optimization, Germany
ARENSIA

Meet the Facilitators

The Spotlight will be lead by our expert facilitators:

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Dr. Natalia Pirtac

Manager Trial Optimization, Germany ARENSIA

More about ARENSIA

More information

ARENSIA EXPLORATORY MEDICINE is a German operator of proprietary research clinics, dedicated to performing complex Phase Ib, IIa and PROOF-OF-CONCEPT clinical trials with novel molecules, involving patients across numerous disease areas. Given the outstanding patient recruitment rates achieved by ARENSIA clinics, we are able to substantially reduce the overall number of sites, countries and recruitment periods for any early phase patient trial.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials ARENSIA Spotlight

ARENSIA Spotlight -1st November 2022

ARENSIA Spotlight

The New Normal In Exploratory Clinical Trials : Challenges and Future Trends

Our Unique Meeting Format

Our Unique Meeting Format

Registration, Networking & Cocktails

Welcome and Introduction New normal in exploratory clinical trials. Challenges and Future Trends

ROUNDTABLE DISCUSSION Accelerated performance of complex exploratory patient studies: Practical insights from investigational site

Dinner

ROUNDTABLE DISCUSSION

Closing Remarks Coffee etc

Meet the Facilitators

Claudia Hesselmann, PhD

Dr. Natalia Pirtac

More about ARENSIA

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3

Phase 4